These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17036642)

  • 1. Prevalence of compounding in independent community pharmacy practice.
    McPherson TB; Fontane PE; Jackson KD; Martin KS; Berry T; Chereson R; Bilger R
    J Am Pharm Assoc (2003); 2006; 46(5):568-73. PubMed ID: 17036642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of pharmaceutical care among pharmacists offering compounding services.
    Yancey V; Yakimo R; Perry A; McPherson TB
    J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized compounding in community pharmacies: organizational perspective.
    Giam JA; McLachlan AJ; Krass I
    J Am Pharm Assoc (2003); 2010; 50(3):354-61. PubMed ID: 20452908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-centered care in the community-based compounding practice setting.
    McPherson T; Fontane P
    J Am Pharm Assoc (2003); 2010; 50(1):37-44. PubMed ID: 20097638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding practices and beliefs of Arizona pharmacists.
    Cauthon KA; Bowman BJ; Gurney MK
    Int J Pharm Compd; 2013; 17(2):154-61. PubMed ID: 23696176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy communications with physician offices to clarify prescriptions.
    Smith M; Sprecher B
    J Am Pharm Assoc (2003); 2017; 57(2):178-182. PubMed ID: 28161301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacy in the United Arab Emirates: characteristics and workforce issues.
    Hasan S; Sulieman H; Chapman C; Stewart K; Kong DC
    Int J Pharm Pract; 2011 Dec; 19(6):392-9. PubMed ID: 22060234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practices of pharmacies that compound extemporaneous formulations.
    Treadway AK; Craddock D; Leff R
    Am J Health Syst Pharm; 2007 Jul; 64(13):1403-9. PubMed ID: 17592006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of job satisfaction for compounders and noncompounders.
    Letendre WR; Shepherd MD; Brown CM
    Int J Pharm Compd; 1998; 2(6):455-62. PubMed ID: 23988321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study.
    Doucette WR; Kreling DH; Schommer JC; Gaither CA; Mott DA; Pedersen CA
    J Am Pharm Assoc (2003); 2006; 46(3):348-55. PubMed ID: 16739756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community and ambulatory pharmacy: evaluation of patient care services and billing patterns before implementation of Medicare part D.
    Beatty SJ; Rodis JL; Bellebaum KL; Mehta BH
    J Am Pharm Assoc (2003); 2006; 46(6):707-14. PubMed ID: 17176686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent community pharmacists' perspectives on compounding in contemporary pharmacy education.
    Martin KS; McPherson TB; Fontane PE; Berry T; Chereson R; Bilger R
    Am J Pharm Educ; 2009 May; 73(3):54. PubMed ID: 19564997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.